Deep Track Capital, LP Crinetics Pharmaceuticals, Inc. Transaction History

Deep Track Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$15.49 - $19.05 $64,608 - $79,457	-4,171 Reduced 0.4%	1,048,829 $19.2 Million
Q2 2022 Aug 12, 2022	SELL	$16.49 - $27.64 $8.06 Million - $13.5 Million	-488,715 Reduced 31.7%	1,053,000 $19.6 Million
Q1 2022 May 16, 2022	SELL	$17.15 - $28.31 $6.14 Million - $10.1 Million	-358,285 Reduced 18.86%	1,541,715 $33.8 Million
Q4 2021 Feb 14, 2022	BUY	$19.35 - $28.41 $36.8 Million - $54 Million	1,900,000 New	1,900,000 $54 Million

241

79.6M

23.3K

44.3K

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.94B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.